Evidence map›Paper›PMID 24626199›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.

Kenneth K Karanja, Eu Han Lee, Eric A Hendrickson, Judith L Campbell

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. TCAF1 promotes TRPV2-mediated CaNature communications · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. International journal of molecular sciences · 2021
    Review
  13. Article
  14. Article
  15. Fanconi anemia and the underlying causes of genomic instability.Environmental and molecular mutagenesis · 2020
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. CaMolecular cell · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Kenneth K KaranjaBraun Laboratories; California Institute of Technology; Pasadena, CA USA.
Eu Han LeeDepartment of Biochemistry, Molecular Biology, and Biophysics; University of Minnesota; Minneapolis, MN USA.
Eric A HendricksonDepartment of Biochemistry, Molecular Biology, and Biophysics; University of Minnesota; Minneapolis, MN USA.
Judith L CampbellBraun Laboratories; California Institute of Technology; Pasadena, CA USA.
Pasadena City College · USUniversity of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
The mechanism of Cas9/CRISPR-initiated genome modification in human somatic cellsR01GM088351 · NIGMS · UNIVERSITY OF MINNESOTA · PI HENDRICKSON, ERIC A · 2010 to 2018
$2.3M
Ku regulates non-homologous end joining pathways in human somatic cellsR01CA154461 · NCI · UNIVERSITY OF MINNESOTA · PI HENDRICKSON, ERIC A · 2011 to 2015
$1.6M
NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA154461NIGMS NIH HHS R01 GM088351
6 · The paper itself

Abstract

FANCD2 is required for the repair of DNA damage by the FA (Fanconi anemia) pathway, and, consequently, FANCD2-deficient cells are sensitive to compounds such as cisplatin and formaldehyde that induce DNA:DNA and DNA:protein crosslinks, respectively. The DNA2 helicase/nuclease is required for RNA/DNA flap removal from Okazaki fragments during DNA replication and for the resection of DSBs (double-strand breaks) during HDR (homology-directed repair) of replication stress-induced damage. A knockdown of DNA2 renders normal cells as sensitive to cisplatin (in the absence of EXO1) and to formaldehyde (even in the presence of EXO1) as FANCD2(-/-) cells. Surprisingly, however, the depletion of DNA2 in FANCD2-deficient cells rescues the sensitivity of FANCD2(-/-) cells to cisplatin and formaldehyde. We previously showed that the resection activity of DNA2 acts downstream of FANCD2 to insure HDR of the DSBs arising when replication forks encounter ICL (interstrand crosslink) damage. The suppression of FANCD2(-/-) by DNA2 knockdowns suggests that DNA2 and FANCD2 also have antagonistic roles: in the absence of FANCD2, DNA2 somehow corrupts repair. To demonstrate that DNA2 is deleterious to crosslink repair, we used psoralen-induced ICL damage to trigger the repair of a site-specific crosslink in a GFP reporter and observed that "over-resection" can account for reduced repair. Our work demonstrates that excessive resection can lead to genome instability and shows that strict regulatory processes have evolved to inhibit resection nucleases. The suppression of FANCD2(-/-) phenotypes by DNA2 depletion may have implications for FA therapies and for the use of ICL-inducing agents in chemotherapy.

Indexed as

Cell Line, TumorCisplatinDNA Breaks, Double-StrandedDNA HelicasesDNA RepairFanconi AnemiaFanconi Anemia Complementation Group D2 ProteinFicusinFormaldehydeGenomic InstabilityHumansCisplatinDNA2 protein, humanDNA HelicasesFanconi Anemia Complementation Group D2 ProteinFicusinFormaldehydeDNA2DNA recombinationDNA replicationFANCD2Fanconi anemiaformaldehyde DNA damageinterstrand crosslinks

Identifiers

PMID24626199
PMCPMC4050159
OpenAlexW2036124213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.